Everolimus Tablets

Listing ID #6529796

Get Latest Price

DosageAs per Doctor's Prescription
TreatmentBreast Cancer
Best Before36 Months from Manufacturing
FormTablet
StorageCool and Dry Place
Supply Type Supplier
Preferred Buyer Location All over the world

Product Details

A drug used alone or with other drugs to treat certain types of breast cancer, kidney cancer, and pancreatic, lung, and gastrointestinal neuroendocrine tumors. It is used under the brand name Afinitor to treat these cancers and to treat a type of benign kidney tumor called renal angiomyolipoma and a type of benign brain tumor called subependymal giant cell astrocytoma in patients who have tuberous sclerosis. Everolimus is also used under the brand name Afinitor Disperz to treat subependymal giant cell astrocytoma and certain types of seizures in patients who have tuberous sclerosis. It is also used under the brand name Zortress to keep the body from rejecting a kidney or liver transplant. Everolimus is also being studied in the treatment of other conditions and types of cancer. It blocks a protein involved in cell division, which may help keep abnormal cells, including cancer cells, from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Everolimus also lowers the body’s immune response. It is a type of kinase inhibitor, a type of angiogenesis inhibitor, and a type of immunosuppressant. Also called RAD001.

Everolimus, sold under the brand name Afinitor among others, is a medication used as an immunosuppressant to prevent rejection of organ transplants and as a targeted therapy in the treatment of renal cell cancer and other tumours

Everolimus is approved to treat:

Breast cancer. It is used in combination with exemestane in postmenopausal women with advanced hormone receptor–positive (HR+) breast cancer that is also HER2 negative (HER2-) and has not gotten better after treatment with letrozole or anastrozole
Pancreatic cancer, gastrointestinal cancer, and lung cancer (certain types). It is used in adults with progressive neuroendocrine tumors that cannot be removed by surgery, are locally advanced, or have metastasized (spread to other parts of the body).
Renal cell carcinoma (a type of kidney cancer) that is advanced, in adults who have not gotten better after treatment with sunitinib or sorafenib.
Subependymal giant cell astrocytoma in adults and children aged 1 year or older who have tuberous sclerosis and are not able to have surgery.

Company Details

Established in 2016, Medicant Healthcare has secured a noticeable position among the Exporter and service providers of good quality Pharmaceutical Medicines and Cancer Drugs. Our drugs are designed following the FDA norms under the strict supervision of qualified experts. Our product range comprises Ulcerative Colitis, Uterus Cancer, Thyroid Cancer, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Lung Cancer, Kidney Cancer, Gastric Cancer, Immunology, and Colorectal Cancer. Known for their fast and long-lasting results, these drugs are rather demanded around the world.

For the secure and hygienic design of the available drugs, we have established a roomy infrastructure, which is further segregated into numerous departments. The departments are capable of advanced machines, which are upgraded according to the present market demands.

A well-maintained warehouse makes sure useful storage of the offered products. According to the vast and trustworthy logistic partners, we bring our products to the customer’s end within the set time frame. Moreover, our drugs are made available at an affordable market cost.

Our revered mentors, Mr. Akhilesh Chaudhary, motivate the team with their rich industry knowledge and experience. The prime focus is on offering a smooth and pressure-free work setting for the employees and has assisted them to give their best. Additionally, they have enabled the company in gaining a strong market stand among the manufacturers and suppliers of excellent quality pharmaceutical medicines and cancer drugs.